Exchange: NYSE·Updated 04:24 PM EST

ELAN News

News
all
press releases
ADUS or ELAN: Which Is the Better Value Stock Right Now?
ADUS vs. ELAN: Which Stock Is the Better Value Option?
Zacks
ADUS or ELAN: Which Is the Better Value Stock Right Now?
ADUS vs. ELAN: Which Stock Is the Better Value Option?
Zacks
More News
Elanco Animal Health (NYSE:ELAN - Get Free Report) announced that its Board of Directors has initiated a share buyback plan on Thursday, November 19th, RTT News reports. The company plans to repurchase $600 million in outstanding shares. This repurchase authorization allows the company to purchase...
MarketBeat
Barclays raised their target price on shares of Elanco Animal Health from $30.00 to $32.00 and gave the stock an "overweight" rating in a report on Thursday...
MarketBeat
Elanco Announces Inaugural $600 Million Share Repurchase Authorization Elanco Announces Inaugural $600 Million Share Repurchase AuthorizationPR NewswireINDIANAPOLIS, Nov. 19, 2026 Reflects Strengthening Financial Profile, Strong Cash Flow Generation, Successful Balance Sheet De-Leveraging Below 3x...
PR Newswire
Elanco to Participate in Upcoming Investor Conferences Elanco to Participate in Upcoming Investor ConferencesPR NewswireINDIANAPOLIS, Nov. 18, 2026 INDIANAPOLIS, Nov. 18, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that management will participate in upcoming...
PR Newswire
Elanco Animal Health Incorporated (NYSE:ELAN - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the thirteen analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have issued a...
MarketBeat
Key PointsThird-quarter organic constant currency revenue grew 9% year over year...
Nasdaq News: Markets
Elanco Animal Health beats Q3 earnings and revenue estimates, driven by Pet Health demand and pricing gains, while raising its full-year 2026 outlook.read more...
Benzinga
The headline numbers for Elanco Animal Health (ELAN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +35.00% and +4.91%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.